Evidence map›Paper›PMID 33748917›Full record

ArticleWorld journal of microbiology & biotechnology2021

Streptomyces tunisiensis DSM 42037 mediated bioconversion of ferulic acid released from barley bran.

Nedra Slama, Houda Mankai, Ferid Limam

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nedra SlamaLaboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia.
Houda MankaiLaboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia.
Ferid LimamLaboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia. limam_ferid@yahoo.fr.ORCID http://orcid.org/0000-0002-2348-826X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces tunisiensis DSM 42037 exhibited growth capacity on a minimum medium containing 1% barley bran. This peculiar strain released 83.5% of total ferulic acid present in barley bran after 5 days of incubation and the highest amount of released ferulic acid (19 mg/L) was observed on the 3rd day of incubation. The concentrated supernatant of S. tunisiensis also released ferulic acid from the parietal arabinoxylan complex of barley bran. This strain was able to convert the free ferulic acid into 4-vinyl guaiacol (14 mg/L) and acetovanillone (12 mg/L) at molar yield of 97% and 83% respectively. The biotransformation products were successively purified by preparative thin layer and silica gel column chromatography followed by HPLC and identified by

Indexed as

BiotransformationCoumaric AcidsCulture MediaGuaiacolHordeumHydroxybenzoatesKineticsPlant ExtractsStreptomycesVanillic AcidCoumaric AcidsCulture Mediaferulic acidGuaiacolHydroxybenzoatesphenolic acidPlant ExtractsVanillic Acid4-vinylguaiacolAcetovanilloneBioconversionDSM 42037Ferulic acidStreptomyces tunisiensis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.